|
US3480613A
(en)
|
1967-07-03 |
1969-11-25 |
Merck & Co Inc |
2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
|
|
US6128582A
(en)
|
1996-04-30 |
2000-10-03 |
Vertex Pharmaceuticals Incorporated |
Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them
|
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
|
GB9707659D0
(en)
|
1997-04-16 |
1997-06-04 |
Peptide Therapeutics Ltd |
Hepatitis C NS3 Protease inhibitors
|
|
ATE283865T1
(de)
|
1997-08-11 |
2004-12-15 |
Boehringer Ingelheim Ca Ltd |
Peptidanaloga mit inhibitorischer wirkung auf hepatitis c
|
|
IL134232A0
(en)
|
1997-08-11 |
2001-04-30 |
Boehringer Ingelheim Ca Ltd |
Hepatitis c inhibitor peptides
|
|
IT1299134B1
(it)
|
1998-02-02 |
2000-02-29 |
Angeletti P Ist Richerche Bio |
Procedimento per la produzione di peptidi con proprieta' inibitrici della proteasi ns3 del virus hcv, peptidi cosi' ottenibili e peptidi
|
|
DK1058686T3
(da)
|
1998-02-25 |
2007-03-05 |
Univ Emory |
2'-fluornukleosider
|
|
GB9806815D0
(en)
|
1998-03-30 |
1998-05-27 |
Hoffmann La Roche |
Amino acid derivatives
|
|
JP4690545B2
(ja)
|
1998-03-31 |
2011-06-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
セリンプロテアーゼ、特にｃ型肝炎ウイルスｎｓ３プロテアーゼの阻害因子
|
|
GB9812523D0
(en)
|
1998-06-10 |
1998-08-05 |
Angeletti P Ist Richerche Bio |
Peptide inhibitors of hepatitis c virus ns3 protease
|
|
EP1106626B1
(en)
|
1998-08-10 |
2003-05-28 |
Hokkaido Electric Power Company, Incorporated |
Process for the preparation of regular glycopeptides
|
|
US6323180B1
(en)
*
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
|
CA2348234A1
(en)
|
1998-10-29 |
2000-05-11 |
Chunjian Liu |
Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
|
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
|
US6608027B1
(en)
*
|
1999-04-06 |
2003-08-19 |
Boehringer Ingelheim (Canada) Ltd |
Macrocyclic peptides active against the hepatitis C virus
|
|
AU780973B2
(en)
|
1999-06-25 |
2005-04-28 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of carbamate inhibitors of IMPDH
|
|
AU763356C
(en)
|
1999-12-27 |
2004-08-26 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
|
US6455508B1
(en)
|
2000-02-15 |
2002-09-24 |
Kanda S. Ramasamy |
Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
|
|
PL364995A1
(en)
|
2000-02-18 |
2004-12-27 |
Shire Biochem Inc. |
Method for the treatment or prevention of flavivirus
|
|
WO2001077113A2
(en)
|
2000-04-05 |
2001-10-18 |
Schering Corporation |
Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
|
|
AU2001253206A1
(en)
|
2000-04-05 |
2001-10-23 |
Tularik, Inc. |
Ns5b hcv polymerase inhibitors
|
|
US7094770B2
(en)
|
2000-04-13 |
2006-08-22 |
Pharmasset, Ltd. |
3′-or 2′-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
EA200601591A1
(ru)
|
2000-05-26 |
2007-02-27 |
Айденикс (Кайман) Лимитед |
Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
|
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
|
ATE448019T1
(de)
|
2000-08-10 |
2009-11-15 |
Trustees Boston College |
Wiederverwendbare methathese-katalysatoren
|
|
US6955174B2
(en)
*
|
2000-08-18 |
2005-10-18 |
Uryovascular Systems, Inc. |
Cryotherapy method for detecting and treating vulnerable plaque
|
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
|
WO2002020497A1
(fr)
|
2000-09-01 |
2002-03-14 |
Shionogi & Co., Ltd. |
Composés ayant une action inhibitrice du virus de l'hépatite c
|
|
EP1411954B1
(en)
|
2000-10-18 |
2010-12-15 |
Pharmasset, Inc. |
Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
|
|
AU2002236591B2
(en)
|
2000-12-12 |
2005-07-14 |
Schering Corporation |
Diaryl peptides as NS3-serine protease inhibitors of hepatits C virus
|
|
AU2002230763A1
(en)
|
2000-12-13 |
2008-01-03 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
|
CN1527836A
(zh)
|
2000-12-15 |
2004-09-08 |
|
用于治疗黄病毒科病毒感染的抗病毒剂
|
|
JPWO2002051425A1
(ja)
|
2000-12-26 |
2004-04-22 |
三菱ウェルファーマ株式会社 |
Ｃ型肝炎治療剤
|
|
RS50236B
(sr)
*
|
2001-01-22 |
2009-07-15 |
Merck & Co.Inc., |
Nukleozidni derivati kao inhibitori rnk-zavisne rnk virusne polimeraze
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
JP4537057B2
(ja)
|
2001-08-14 |
2010-09-01 |
テルアビブ・ユニバーシティ・フューチャー・テクノロジー・デベロップメント・エルピー |
脂質化グリコサミノグリカン粒子ならびに診断及び処置のための薬物及び遺伝子送達におけるその使用
|
|
WO2003026589A2
(en)
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
|
EP1438054A4
(en)
|
2001-09-28 |
2006-07-26 |
Idenix Cayman Ltd |
METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS USING MODIFIED NUCLEOSIDE AT 4 'POSITION
|
|
JP2005515254A
(ja)
|
2002-01-17 |
2005-05-26 |
スミスクライン ビーチャム コーポレーション |
カテプシンｋ阻害剤として有用なシクロアルキルケトアミド誘導体
|
|
GB0201179D0
(en)
|
2002-01-18 |
2002-03-06 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
CA2369711A1
(en)
|
2002-01-30 |
2003-07-30 |
Boehringer Ingelheim (Canada) Ltd. |
Macrocyclic peptides active against the hepatitis c virus
|
|
US7323453B2
(en)
|
2002-02-13 |
2008-01-29 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
|
US6777392B2
(en)
|
2002-03-28 |
2004-08-17 |
Council Of Scientific And Industrial Research |
8-(C-β-D-glucopyranosyl)-7, 3', 4'-trihydroxyflavone, process of isolation thereof, pharmaceutical composition and method for the treatment of diabetes
|
|
EP1501850A2
(en)
|
2002-05-06 |
2005-02-02 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis c virus infection
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
JP2005530843A
(ja)
|
2002-06-21 |
2005-10-13 |
メルク エンド カムパニー インコーポレーテッド |
Ｒｎａ依存性ｒｎａウィルスポリメラーゼ阻害剤としてのヌクレオシド誘導体
|
|
WO2004003138A2
(en)
|
2002-06-27 |
2004-01-08 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
CN104193791A
(zh)
|
2002-06-28 |
2014-12-10 |
埃迪尼克斯医药公司 |
用于治疗黄病毒感染的修饰的2’和3’-核苷前药
|
|
KR20050055630A
(ko)
|
2002-06-28 |
2005-06-13 |
이데닉스 (케이만) 리미티드 |
플라비비리다에 감염 치료를 위한 1'-, 2'- 및 3'-변형된뉴클레오시드 유도체
|
|
BR0312278A
(pt)
|
2002-06-28 |
2007-06-19 |
Idenix Cayman Ltd |
éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
|
|
JP2005533108A
(ja)
|
2002-07-16 |
2005-11-04 |
メルク エンド カムパニー インコーポレーテッド |
Ｒｎａ依存性ｒｎａウイルスポリメラーゼの阻害剤としてのヌクレオシド誘導体
|
|
US20050026853A1
(en)
|
2002-07-25 |
2005-02-03 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza D-nucleosides and uses thereof
|
|
MXPA05001298A
(es)
|
2002-08-01 |
2005-11-04 |
Pharmasset Inc |
Compuestos con el sistema biciclo[4.2.1] nonano para el tratamiento de infecciones por flaviviridae.
|
|
AU2003279797B2
(en)
|
2002-09-30 |
2009-10-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
|
BR0315937A
(pt)
|
2002-11-01 |
2005-09-13 |
Viropharma Inc |
Composto, composição para a profilaxia ou tratamento de infecções virais, e, método para a profilaxia ou tratamento de infecções da hepatite c e doenças associadas com tais infecções em um hospedeiro vivo
|
|
US20040254159A1
(en)
*
|
2003-02-27 |
2004-12-16 |
Hasvold Lisa A. |
Heterocyclic kinase inhibitors
|
|
EP1601685A1
(en)
*
|
2003-03-05 |
2005-12-07 |
Boehringer Ingelheim International GmbH |
Hepatitis c inhibiting compounds
|
|
WO2004093915A1
(en)
|
2003-04-02 |
2004-11-04 |
Boehringer Ingelheim International, Gmbh |
Pharmaceutical compositions for hepatitis c viral protease inhibitors
|
|
GB0307891D0
(en)
|
2003-04-04 |
2003-05-14 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
|
ES2320771T3
(es)
*
|
2003-04-16 |
2009-05-28 |
Bristol-Myers Squibb Company |
Inhibidores peptidicos de isoquinolina macrociclicos del virus de la hepatitis c.
|
|
US7176208B2
(en)
*
|
2003-04-18 |
2007-02-13 |
Enanta Pharmaceuticals, Inc. |
Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
|
|
UA83046C2
(ru)
|
2003-05-21 |
2008-06-10 |
Берингер Ингельхайм Интернациональ Гмбх |
Соединения как ингибиторы вируса гепатита с, фармацевтическая композиция на их основе
|
|
US7429572B2
(en)
|
2003-05-30 |
2008-09-30 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
|
GB0313250D0
(en)
|
2003-06-09 |
2003-07-16 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
ES2276311T3
(es)
|
2003-06-19 |
2007-06-16 |
F. Hoffmann-La Roche Ag |
Proceso para praderar derivados de 4' -azidonucleosido.
|
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
|
GB0321003D0
(en)
|
2003-09-09 |
2003-10-08 |
Angeletti P Ist Richerche Bio |
Compounds, compositions and uses
|
|
GB0323845D0
(en)
|
2003-10-10 |
2003-11-12 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
|
US7132504B2
(en)
|
2003-11-12 |
2006-11-07 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2005070955A1
(en)
|
2004-01-21 |
2005-08-04 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis c virus
|
|
JP4143669B2
(ja)
|
2004-02-24 |
2008-09-03 |
日本たばこ産業株式会社 |
４環縮合複素環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用
|
|
GB0413087D0
(en)
|
2004-06-11 |
2004-07-14 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
GB0416396D0
(en)
|
2004-07-22 |
2004-08-25 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
US7153848B2
(en)
|
2004-08-09 |
2006-12-26 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
|
CN101044151B
(zh)
|
2004-08-23 |
2011-01-19 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4＇-叠氮基-核苷
|
|
GB0419850D0
(en)
|
2004-09-07 |
2004-10-13 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
PE20060607A1
(es)
|
2004-10-26 |
2006-07-14 |
Angeletti P Ist Richerche Bio |
Derivados de indol tetraciclicos como agentes antivirales
|
|
US7834145B2
(en)
|
2005-03-22 |
2010-11-16 |
Merck Sharp & Dohme Corp. |
HCV protease substrates
|
|
WO2006119061A2
(en)
*
|
2005-05-02 |
2006-11-09 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
|
GB0509326D0
(en)
|
2005-05-09 |
2005-06-15 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
US7470664B2
(en)
*
|
2005-07-20 |
2008-12-30 |
Merck & Co., Inc. |
HCV NS3 protease inhibitors
|
|
US7462035B2
(en)
|
2005-07-27 |
2008-12-09 |
Physical Optics Corporation |
Electrical connector configured as a fastening element
|
|
NZ565269A
(en)
*
|
2005-08-01 |
2010-03-26 |
Merck & Co Inc |
Macrocyclic peptides as HCV NS3 protease inhibitors
|
|
WO2007028789A1
(en)
|
2005-09-07 |
2007-03-15 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Quinazoline derivatives as antiviral agents
|
|
GB0518390D0
(en)
|
2005-09-09 |
2005-10-19 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
GB0519797D0
(en)
|
2005-09-29 |
2005-11-09 |
Istituto Di Ricerche D Biolog |
Therapeutic agents
|
|
GB0609492D0
(en)
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
WO2007145894A2
(en)
|
2006-06-08 |
2007-12-21 |
Merck & Co., Inc. |
A rapid method to determine inhibitor sensitivity of ns3/4a protease sequences
|
|
GB0612423D0
(en)
|
2006-06-23 |
2006-08-02 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
UY30437A1
(es)
|
2006-06-26 |
2008-01-31 |
Enanta Pharm Inc |
Quinoxalinil macroceclicos inhibidores de serina proteasa del virus de la hepatitis c
|
|
US8377873B2
(en)
*
|
2006-10-24 |
2013-02-19 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
|
JP5345541B2
(ja)
|
2006-10-24 |
2013-11-20 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Ｈｃｖｎｓ３プロテアーゼ阻害剤
|
|
JP5345941B2
(ja)
|
2006-10-24 |
2013-11-20 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Ｈｃｖｎｓ３プロテアーゼ阻害剤
|
|
US8377874B2
(en)
*
|
2006-10-27 |
2013-02-19 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
|
WO2008057209A1
(en)
*
|
2006-10-27 |
2008-05-15 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
|
CA2705449C
(en)
|
2006-11-09 |
2017-01-10 |
Twinblade Technologies Holding Sweden Ab |
Hub device
|
|
WO2008112108A1
(en)
|
2007-03-09 |
2008-09-18 |
Merck & Co., Inc. |
In vivo hcv resistance to anti-viral inhibitors
|
|
PT2170888E
(pt)
|
2007-06-29 |
2015-08-21 |
Gilead Sciences Inc |
Purina derivados e sua utilização como moduladores de recetor de tipo toll 7
|
|
AU2008277377B2
(en)
|
2007-07-19 |
2013-08-01 |
Msd Italia S.R.L. |
Macrocyclic compounds as antiviral agents
|
|
CL2008003384A1
(es)
|
2007-11-14 |
2009-12-11 |
Enanta Pharm Inc |
Compuestos derivados de quinoxalina macrocíclica, inhibidores de serina proteasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de la hepatitis c.
|
|
CN102026544A
(zh)
|
2007-11-14 |
2011-04-20 |
益安药业 |
大环四唑基丙型肝炎病毒丝氨酸蛋白酶抑制剂
|
|
AU2009241445A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
|
US7973040B2
(en)
|
2008-07-22 |
2011-07-05 |
Merck Sharp & Dohme Corp. |
Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors
|
